Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 2 | -1.35M | 100% | $31.55 | -$42.7M |
Net | -2 | -1.35M | -100% | -$42.7M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Decheng Capital Global Life Sciences Fund IV, L.P. | 10%+ Owner | $175M | Jan 29, 2024 | ||
Hong Fang Song | Director | $118M | -$42.6M | -26.6% | Dec 16, 2024 |
Arthur Kuan | Chief Executive Officer, Director | $1.28M | Oct 4, 2024 | ||
Corleen Roche | Cfo | $70.7K | Oct 4, 2024 | ||
Vijay Kasturi | Chief Medical Officer | $46.5K | Oct 4, 2024 | ||
Leonard Post | Director | $0 | -$63.4K | -100% | Dec 16, 2024 |
James Mulay | Director | Oct 4, 2024 | |||
Brian Liu | Director | Oct 4, 2024 | |||
Victor Tong | Director | Oct 4, 2024 | |||
Susan Graf | Director | Oct 4, 2024 | |||
Joshua F. Patterson | General Counsel and Chief Compliance Officer | Oct 4, 2024 | |||
Ambaw Bellete | President and COO | Oct 4, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|